1. Home
  2. ISTR vs EDIT Comparison

ISTR vs EDIT Comparison

Compare ISTR & EDIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Investar Holding Corporation

ISTR

Investar Holding Corporation

HOLD

Current Price

$30.22

Market Cap

394.5M

Sector

Finance

ML Signal

HOLD

Logo Editas Medicine Inc.

EDIT

Editas Medicine Inc.

HOLD

Current Price

$3.21

Market Cap

432.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ISTR
EDIT
Founded
2006
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
394.5M
432.8M
IPO Year
2014
2016

Fundamental Metrics

Financial Performance
Metric
ISTR
EDIT
Price
$30.22
$3.21
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$31.50
$5.30
AVG Volume (30 Days)
113.3K
2.1M
Earning Date
04-20-2026
05-11-2026
Dividend Yield
1.59%
N/A
EPS Growth
4.41
37.50
EPS
1.38
N/A
Revenue
N/A
$31,937,000.00
Revenue This Year
$66.56
N/A
Revenue Next Year
$5.18
N/A
P/E Ratio
$21.96
N/A
Revenue Growth
N/A
132.64
52 Week Low
$21.43
$1.66
52 Week High
$31.27
$4.54

Technical Indicators

Market Signals
Indicator
ISTR
EDIT
Relative Strength Index (RSI) 53.42 56.64
Support Level $28.75 $2.74
Resistance Level $30.53 $3.21
Average True Range (ATR) 0.50 0.20
MACD -0.05 0.04
Stochastic Oscillator 51.98 69.23

Price Performance

Historical Comparison
ISTR
EDIT

About ISTR Investar Holding Corporation

Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashier's checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.

Share on Social Networks: